Saham AS
Closed Market
Saham BridgeBio
•BBIOClosed Market
$65,27
+$1,33(2,04%)Sehari Lalu
-$1,12(1,69%)After Hours
Tentang BridgeBio
BridgeBio Pharma, Inc. terlibat dalam mengidentifikasi dan mengembangkan obat-obatan yang merubah permainan untuk mengobati pasien yang menderita penyakit Mendelian. Perusahaan ini berkantor pusat di Palo Alto, California Baca selengkapnyaSektorHealth Care
IndustriPharmaceuticals, Biotechnology & Life Sciences
ExchangeNASDAQ
Karyawan728
Kantor PusatPalo Alto, United States
Websitebridgebio.com
SimbolBBIO
Statistik Kunci
Umum
Rasio Valuasi
Keuntungan
Kapitalisasi Pasar0
Dividend Yield$0
Avg. Volume0
Earnings per Share$0
Enterprise Value (EV)$0
52w High$0 (Invalid Date)
52w Low$0 (Invalid Date)
1Y Drawdown0%
EBITDA$0
PEG Ratio0,00
Pengguna Lain Sedang Membeli
GOOG
ABCL
FUTU
BILL
FIGS
TECH
NVS
DOCN
CUBE
INO
AMPL
A
FNKO
NRDS
ONLGOOGABCLFUTUBILLFIGSTECHNVSDOCNCUBEINOAMPLAFNKONRDSONL
GOOG$288,25
+4,07%
ABCL$3,79
+2,71%
FUTU$170
+2,55%
BILL$51,93
+3,14%
FIGS$9,48
+2,60%
TECH$60,56
+1,99%
NVS$134
+2,09%
DOCN$47,43
+3,47%
CUBE$37,63
+2,76%
INO$2,1
+2,42%
AMPL$11,01
+2,61%
A$149,73
+1,98%
FNKO$3,36
+3,38%
NRDS$14,64
+4,72%
ONL$2,45
+2,08%
GOOG$288,25
+4,07%
ABCL$3,79
+2,71%
FUTU$170
+2,55%
BILL$51,93
+3,14%
FIGS$9,48
+2,60%
TECH$60,56
+1,99%
NVS$134
+2,09%
DOCN$47,43
+3,47%
CUBE$37,63
+2,76%
INO$2,1
+2,42%
AMPL$11,01
+2,61%
A$149,73
+1,98%
FNKO$3,36
+3,38%
NRDS$14,64
+4,72%
ONL$2,45
+2,08%
